Navigation Links
Symmetry Medical Reports Record First Quarter 2008 Revenue of $101.9 Million

Increases Full Year Revenue Guidance to a range of $395 Million to $405

Million; Provides Full Year EPS Guidance of $0.75 to $0.77

First Quarter 2008 Highlights:

- Revenue of $101.9 million, up 57.4% over first quarter 2007

- Gross profit of $23.9 million, up 104.4% over first quarter 2007 - Operating income of $9.6 million, up 135.4% over first quarter 2007

WARSAW, Ind., June 24 /PRNewswire-FirstCall/ -- Symmetry Medical Inc. (NYSE: SMA), a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced today first quarter 2008 financial results for the period ended March 29, 2008.

The Company reported first quarter 2008 revenue of $101.9 million, an increase of 57.4% from the $64.7 million reported in the first quarter 2007, and an increase of 26.3% from the $80.7 million reported for the fourth quarter 2007. The Company's first quarter 2008 revenue included $1.8 million from TNCO, Inc., which was acquired in April 2007; $5.9 million from Specialty Surgical Instrumentation Inc., which was acquired in August 2007; and $7.7 million from our New Bedford, Massachusetts manufacturing facility, which was acquired from DePuy Orthopaedics, Inc. in January 2008.

Gross profit for the first quarter 2008 was $23.9 million, a 104.4% increase from gross profit of $11.7 million for the first quarter 2007. Gross margin percentage for the first quarter 2008 was 23.5%, compared to gross margin percentage of 18.1% for the first quarter 2007. Gross margin for the first quarter of 2008 was unfavorably impacted by negative gross margin incurred at the Company's Sheffield, UK operating unit.

Selling, general and administrative expenses were $14.4 million for the first quarter 2008 compared to $7.7 million in the first quarter 2007. The year-over-year increase was primarily driven by the inclusion of $2.7 million of expense from acquisitions and $2.2 million in professional fees and expenses incurred in connection with the review of accounting irregularities at the Company's Sheffield, UK operating unit. This increase was also due to initiatives at the Company's Sheffield, UK operating unit to improve operational efficiency, meet customer demand and drive increased sales.

Operating income for the first quarter of 2008 was $9.6 million, a 135.4% increase over operating income of $4.1 million for the first quarter 2007. Operating margin for the first quarter 2008 was 9.4%, compared to an operating margin of 6.3% for the first quarter 2007.

Net income for the first quarter 2008 was $4.0 million, or $0.11 per diluted share, compared to net income of $1.6 million, or $0.05 per diluted share, for the first quarter of 2007.

Included in first quarter 2008 results was $2.2 million pre-tax, or ($0.04) per diluted share in professional fees and expenses incurred in connection with the review of accounting irregularities at the Company's Sheffield, UK operating unit and the effects of a net loss at Sheffield of $1.9 million or ($0.05) per diluted share.

The weighted average number of diluted shares outstanding during the first quarter of 2008 was 35,335,000.

Brian Moore, President and Chief Executive Officer, stated, "We are very encouraged by the current state of our business and the increased demand across the orthopaedic market. Our global capacity continues to provide our customers with quality service for their large projects and new product launches. Our recent acquisitions have provided the expanded capabilities and capacity that allow us to respond quickly to the demands of the current industry environment. We are especially pleased with the performance at our recently acquired New Bedford, Massachusetts manufacturing facility. This facility has provided Symmetry Medical with a strategic source of increased capacity to serve our customers and has exceeded its production output expectations in the quarter."

Mr. Moore continued, "While we are pleased by our strong top line quarterly performance, we look forward to an improving bottom line, which was negatively impacted primarily by our Sheffield, UK facility and the ongoing accounting investigation costs. We have several strategic initiatives in place that we believe will improve the operating and financial performance of Sheffield over the remainder of 2008. We are focused on further improving the facility's operational efficiencies, reducing costs and driving increased revenue growth. During the first quarter, the Sheffield team has spent considerable time, effort and cost to stay responsive to our customer base and maintain the high level of service that Symmetry is known for. Their efforts have restored customer confidence during the first quarter and we are confident that our new management team in Europe, led by John Hynes, will make continued progress. We look forward to the close of the accounting investigation and improvements at Sheffield and expect the facility to return to profitability in the fourth quarter of 2008. We believe this enhanced performance, combined with the current demand of our core business, will contribute to improved overall bottom line results throughout the remainder of the year."

Financial Guidance

The following estimates regarding 2008 earnings guidance are based on current market conditions and foreign currency comparisons and are forward-looking. Actual results may differ materially, and we refer you to forward-looking statements appearing at the end of the release.

For the full year 2008, the Company is increasing its revenue guidance to a range of $395 million to $405 million up from our previously announced range of $350 million to $360 million. This increase reflects the current order flow and anticipated customer demand for the remainder of 2008. For the full year 2008, the Company expects earnings per diluted share in the range of $0.75 to $0.77.

As it relates to the Company's Sheffield operating unit, the Company expects to incur a smaller net loss in the second and third quarters of 2008 and expects the unit to reach profitability in the fourth quarter of 2008.

Conference Call

Symmetry Medical will host a conference call at 8:00 a.m. ET on June 24, 2008. A live Web cast of the conference call will be available online from the investor relations page of the Company's corporate website at The dial-in numbers are (866) 271-5140 for domestic callers and (617) 213-8893 for international. The reservation number for both is 69683911. After the live Web cast, the call will remain available on Symmetry Medical's Web site through September 24, 2008. In addition, a telephonic replay of the call will be available until July 1, 2008. The replay numbers are (888) 286-8010 for domestic callers and (617) 801-6888 for international callers. Please use reservation code 77714178.

About Symmetry Medical Inc.

Symmetry Medical Inc. is a leading independent provider of implants and related instruments and cases to the orthopaedic device industry. The Company also designs, develops and produces these products for companies in other segments of the medical device market, including arthroscopy, dental, laparoscopy, osteobiologic and endoscopy sectors and provides limited specialized products and services to non-healthcare markets, such as the aerospace market.

Forward-Looking Statements

Statements in the press release regarding Symmetry Medical Inc.'s business, which are not historical facts, may be "forward-looking statements" that involve risks and uncertainties, within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are predictive in nature and are frequently identified by the use of terms such as "may," "might," "will," "should," "expect," "believe," "anticipate," "plan," "estimate," "intend," and similar words indicating possible future expectations, events or actions. Such predictive statements are not guarantees of future performance, and actual outcomes and results could differ materially from our current expectations. We refer you to the "Risk Factors" and "Forward Looking-Statements" sections in the Company's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission as well as the Company's other filings with the SEC, which are available on the SEC's Web site at

Investors/Media: Contact:

The Ruth Group Symmetry Medical Inc.

Nick Laudico/Jason Rando Fred Hite

646-536-7030/7025 Senior Vice President Chief Financial Officer (574) 371-2218

Symmetry Medical Inc.

Consolidated Statements of Operations

Three Months Ended

March 29, March 31,

2008 2007


(In Thousands, Except Per

Share Data)

Revenue $101,862 $64,724

Cost of Revenue 77,916 53,010

Gross Profit 23,946 11,714

Selling, general, and administrative 14,382 7,651

Operating Income 9,564 4,063

Other (income) expense:

Interest expense 2,700 1,587

Derivatives valuation (gain)/loss 1,165 (295)

Other (income) expense (162) 659

Income before income taxes 5,861 2,112

Income tax expense 1,894 497

Net income $3,967 $1,615

Net income per share:

Basic $0.11 $0.05

Diluted $0.11 $0.05

Weighted average common shares and

equivalent shares outstanding:

Basic 35,153 34,973

Diluted 35,335 35,194

Symmetry Medical Inc.

Consolidated Balance Sheets

March 29, December 29,

2008 2007

(In Thousands, Except Per

Share Data)



Current Assets:

Cash and cash equivalents $9,346 $12,089

Accounts receivables, net 62,943 42,992

Inventories 56,483 45,353

Refundable income taxes 5,698 6,516

Deferred income taxes 3,286 2,551

Derivative valuation asset 40 2

Other current assets 3,418 2,940

Total current assets 141,214 112,443

Property and equipment, net 121,739 100,424

Goodwill 154,962 141,985

Intangible assets, net of accumulated

amortization 48,402 44,567

Other assets 2,437 1,011

Total Assets $468,754 $400,430

Liabilities and Shareholders' Equity:

Current Liabilities:

Accounts payable $37,411 $34,518

Accrued wages and benefits 10,606 10,922

Other accrued expenses 8,231 8,096

Income tax payable 4,433 2,394

Derivative valuation liability - 74

Deferred income taxes 460 407

Revolving line of credit 7,645 6,511

Current portion of capital lease obligations 2,052 2,487

Current portion of long-term debt 12,150 10,900

Total current liabilities 82,988 76,309

Deferred income taxes 12,330 12,136

Derivative valuation liability 3,220 1,917

Capital lease obligations, less current portion 3,623 4,032

Long-term debt, less current portion 122,000 68,500

Total Liabilities 224,161 162,894

Shareholders' Equity:

Common Stock, $.0001 par value; 72,410 shares

authorized; shares issued March 29, 2008

-- 35,467; December 29, 2007 -- 35,444) 4 4

Additional paid-in capital 272,971 272,623

Retained earnings (deficit) (41,559) (45,526)

Accumulated other comprehensive income 13,177 10,435

Total Shareholders' Equity 244,593 237,536

Total Liabilities and Shareholders' Equity $468,754 $400,430

SOURCE Symmetry Medical Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
2. Symmetry Medical Launches New Global Web site
3. Symmetry Medical Appoints John Hynes Chief Operating Officer, Europe
4. Symmetry Medical Provides Update of Previously Disclosed Accounting Review at Sheffield, UK Operating Unit
5. Symmetry Medical Completes Acquisition of DePuy Orthopaedic Instrument Facility
6. Symmetry Medical to Provide Fourth Quarter 2007 General Business Update on February 14, 2008
7. Facial asymmetry persists despite surgery to correct congenital deformity
8. Symmetry Medical to Expand Malaysian Operations
9. Symmetry Medical Delays 10-K Filing to Complete Review
10. Symmetry Medical Reports Full Year 2007 Financial Results
11. Symmetry Medical to Report First Quarter 2008 Financial Results on June 24, 2008
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills ... specialty vendors and unique items from across the nation, this holiday-themed event will raise ... offered by the VNA. The boutique will be open Saturday, November 4 (10:00 ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Agile Software Development, has been awarded a contract by the Center for Medicare ... (BPA) aims to accelerate the enterprise use of Agile methodologies in a consistent ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the ... today its plans to open a flagship location in Covington, LA at 401 N. ... To Go store next to Office Depot in the Holiday Square shopping center. Its ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... GRAND RAPIDS, Mich. (PRWEB) , ... October 12, ... ... OnSite Wellness, has been named one of Michigan’s 2017 Best and Brightest in ... Best and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... PARK, Calif. , Oct. 11, 2017  BioPharmX ... national scientific team that developed an innovative way to ... quantity of the delivery of new drugs. ... 2017 Fall Clinical Dermatology Conference will show how researchers ... General Hospital, Harvard Medical School used a suite of ...
(Date:10/10/2017)... EXTON, Pa. , Oct. 10, 2017   ... leader in innovative solutions for injectable drug administration, today ... of West,s ID Adapter for improving the intradermal administration ... the Fourth Skin Vaccination Summit in May 2017 by ... Team Lead, Polio Department, World Health Organization (WHO), and ...
(Date:10/4/2017)... LAWRENCE, Mass. , Oct. 4, 2017 /PRNewswire/ ... developer of single-use, self-contained, illuminating medical devices, today ... National Health Surveillance Agency (or Agência Nacional ... ®. The first single-use, cordless surgical retractor with ... ONETRAC provides optimal access, illumination and exposure of ...
Breaking Medicine Technology: